Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.330
-0.040 (-2.92%)
May 21, 2025, 1:34 PM - Market open
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $81.64 million as of May 21, 2025. Its market cap has decreased by -90.32% in one year.
Market Cap
81.64M
Enterprise Value
-161.37M
1-Year Change
-90.32%
Ranking
Category
Stock Price
$1.33
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $81.64M, a decrease of -88.93%. That is a compound annual growth rate of -35.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2025 | 84.10M | -89.51% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | 806.10M | 9.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.62B |
| Johnson & Johnson | 369.72B |
| AbbVie | 326.52B |
| Novo Nordisk | 305.65B |
| UnitedHealth Group | 291.72B |
| Abbott Laboratories | 235.23B |
| Novartis AG | 219.90B |
| AstraZeneca | 215.95B |